Scientists test first 'Pancoronavirus' shot to block future outbreaks
NCT ID NCT06950177
Summary
This is an early-stage study testing the safety and immune response of a new vaccine designed to protect against multiple coronaviruses, not just the one that causes COVID-19. The study will enroll 51 healthy adults to receive two doses of the experimental vaccine at different strength levels. The main goal is to see if the vaccine is safe and well-tolerated, and to measure the antibody response it creates.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS COV 2 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Health System
Durham, North Carolina, 27709, United States
Conditions
Explore the condition pages connected to this study.